Burning Rock Biotech (BNR) Treasury Shares (2021 - 2023)

Burning Rock Biotech has reported Treasury Shares over the past 2 years, most recently at $9.2 million for Q4 2023.

  • Quarterly results put Treasury Shares at -$62469.2 for Q4 2023, up 86.06% from a year ago — trailing twelve months through Dec 2023 was -$62469.2 (up 86.06% YoY), and the annual figure for FY2023 was -$62469.2, up 86.84%.
  • Treasury Shares for Q4 2023 was $9.2 million at Burning Rock Biotech, up from $8.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for BNR hit a ceiling of -$9545.1 in Q4 2021 and a floor of -$448108.7 in Q4 2022.
  • Median Treasury Shares over the past 3 years was -$62469.2 (2023), compared with a mean of -$173374.3.
  • Peak annual rise in Treasury Shares hit 10.48% in 2023, while the deepest fall reached 10.48% in 2023.
  • Burning Rock Biotech's Treasury Shares stood at -$9545.1 in 2021, then tumbled by 4594.67% to -$448108.7 in 2022, then surged by 86.06% to -$62469.2 in 2023.
  • The last three reported values for Treasury Shares were -$62469.2 (Q4 2023), -$448108.7 (Q4 2022), and -$9545.1 (Q4 2021) per Business Quant data.